Moffitt Researchers Identify Splice Variant Biomarkers in Clear Cell Renal Cell Carcinoma - Newswise

Scientists are trying to improve their understanding of the development of clear cell renal cell carcinoma to develop new targeted therapeutics. In a new study

Newswise — TAMPA, Fla. — Kidney cancer accounts for only 4% of all cancers in the United States; however, its incidence has more than doubled since 1975, with the most common type being clear cell re… [+5026 chars]

full article...